We’re thrilled to share that Dagens Nyheter has featured MyCural in an article, highlighting our journey, future plans, and the latest developments.
An investment round is now ongoing, aimed at increasing capital to accelerate our development efforts. This crucial support from investors enables us to fuel our research, development, and innovation, bringing us closer to our mission of revolutionizing treatment options for cancer patients with severe cancer and a poor prognosis.
“We have an incredibly exciting time ahead of us and are proud of the support from organizations and investors who share our commitment,” says Alina Castell, CEO and Founder of MyCural. “This financial support fuels our research, development, and innovation, driving us closer to our goal of changing the treatment options for cancer patients.”
Through our investment round, we aim to attract more attention and garner support for our groundbreaking work. Together, we hope to make a difference in the lives of cancer patients in the future. Stay tuned for more updates on our progress!
